Premarket Movers | Insmed Shares Jump 10% After Reporting Higher Preliminary 2025 Revenue; Crypto Shares Rise with DeFi Tech up over 4%; TeraWulf up 2%
View all comments(0)
Insmed reported preliminary 2025 revenue Friday of $606.4 million, up 67% year over year. Analysts polled by FactSet expect $518 million.
US revenue for the year grew 78% to $453 million, while international sales jumped 41% to $153.5 million, according to Insmed. The company said it will report final Q4 and 2025 financial results in February. Insmed shares were up 10% in recent premarket activity.

Crypto shares jumped in premarket trading. DeFi Tech up over 4%; IREN up 3%; TeraWulf up 2%.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
Qualcomm Stock Holds Rising Trendline as Amazon AI Deal Puts $182.70 Breakout in Focus

SpaceX Stock Price Forecast: As Stock Lockups Intensify, Can SPCX Peak at $225 by 2027?

Anthropic Targets $2 Trillion Valuation as 2026 US IPO Proceeds Hit Record, Yet New Stocks Lag Market

Salesforce vs. ServiceNow: SaaS Sees AI Turnaround, Which Has More Upside Potential, CRM or NOW?

Tesla Stock Price Forecast: Morgan Stanley Sees Semi Truck Generating $17 Billion in Software Revenue, Can the Stock Continue Its Recovery?






Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.